In the U.S., the recommended immunization series prevents approximately 33,000 deaths each year. Advancements in biotechnology have made it possible to produce vaccines that cannot transmit a virus or bacterium. This method has helped create more than 20 new vaccines against infectious agents, improved existing vaccines, and increased the amount of vaccine that can be produced.
Biotech Response to COVID-19
As the threat of the novel coronavirus continues to grow globally, innovative biopharmaceutical companies are ramping up efforts to study the virus and develop vaccines and cures to protect individuals from contracting the virus.
The Asia Pacific Economic Cooperation (APEC) Leaders Meeting, just like most events these days, took place virtually in November, 2020. President Trump participated in the meeting along with the other 20 leaders…
Even in a global pandemic, there’s one thing that hasn’t changed: the need to get a flu shot.
In fact, receiving a flu shot is more important than ever to avoid burdening the hospitals and health care professionals…
Today, more than 50% of all people living with HIV in the United States are over the age of 50. Ten years from now that percentage is
estimated to go up to 70% and more than four in five people…
As Congress and the new President lay out their aggressive “100 Day Plans,” The Biotechnology Innovation Organization (BIO) today released a new blueprint highlighting goals to strengthen America’s innovation ecosystem, end the COVID-19 pandemic, and get more Americans back to work over the first…
Public opinion polls show there is significant mistrust among the American public in the safety and efficacy of vaccines. So today, the Biotechnology Innovation Organization (BIO) announced the launch of COVIDVaccineFacts.org. As a subsidiary website of BIO, COVIDVaccineFacts.org is an educational…
"What a historic election for our country! For the first time in 120 years, American voter participation shattered many turnout records.
"At BIO we undertook an effort to mobilize and activate voters in our industry with Biotech Votes 2020, and while we certainly did not pick sides or…
On Wednesday, December 23rd, BIO submitted comments on the U.S. Food and Drug Administration (FDA)’s October 2020 public workshop titled, “New Drugs Regulatory Program Modernization: Implementation of the Integrated Assessment of Marketing Applications and Integrated Review Documentation.” In its…
On November 9, BIO submitted comments on the FDA Draft Guidance, Drug-Drug Interaction Assessment for Therapeutic Proteins. In the comments, BIO thanks the FDA for the opportunity to submit comments but requests that the Guidance include a discussion on the potential of generalizing information…
October 30, 2020
Re: Docket No. FDA–2020-D-1564: FDA Draft Guidance, Principles for Selecting, Developing, Modifying, and Adapting Patient-Reported Outcome Instruments for Use in Medical Device Evaluation.
Dear Sir/Madam:
The Biotechnology Innovation Organization (BIO) thanks the Food and Drug…
Become an Advocate for Biotechnology
Sign-up to join BIOAction, BIO's grassroots advocacy program. You will be notified about relevant policy issues where we need you to contact your lawmaker.